Quantum Genomics Société Anonyme (ENXTPA: ALQGC)
Health Care · Biotechnology · FR
€0.07
-0.28% today · -0.3% 1Y
Quantum Genomics Société Anonyme (ENXTPA: ALQGC) operates in the Biotechnology industry within the Health Care sector. The company is valued at $5.65M and employs 3 people.
Over the last twelve months the share price has lost 0.3%.
Tweenvest scores Quantum Genomics Société Anonyme across four factors: quality 26/100, value 68/100. Its strongest factor is value.
ALQGC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.65M
- Revenue (TTM)
- $10.00
- P/E
- —
- EPS
- -0.13
- Dividend yield
- —
- Beta (5Y)
- -0.20
- 52-week high
- €—
- 52-week low
- €—
- Avg volume (3M)
- —
- Shares outstanding
- 69.71M
- Employees
- 3
- Next earnings
- —
About Quantum Genomics Société Anonyme
Quantum Genomics S.A., a biopharmaceutical firm established in Paris, France, in 2005, focuses on creating treatments for cardiovascular ailments. Its therapeutic approach utilizes the brain aminopeptidase A inhibition (BAPAI) platform, primarily addressing high blood pressure (hypertension) and heart failure. The company's key asset, firibastat, is currently undergoing a crucial Phase III study as a standalone therapy for hypertension and is also in clinical trials for heart failure. Additionally, Quantum Genomics is progressing QGC011 for hypertension in combination therapy, and further developing QGC006 and QGC606 to target both hypertension and heart failure.
- ISIN
- FR0011648971
- Founded
- 2005
- Listed since
- May 28, 2010
- Exchange
- Euronext Paris
- Currency
- EUR
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| OLIPASS CorporationKOSDAQ: A244460 | $5.72M | ₩— | — |
| Imunon, Inc.NasdaqCM: IMNN | $5.72M | $1.02 | -5.56% |
| AquaBounty Technologies, Inc.NasdaqCM: AQB | $5.71M | $1.11 | +8.82% |
| NeuroSense Therapeutics Ltd.NasdaqCM: NRSN | $5.68M | $3.07 | -16.12% |
| LianMedicalOTCPK: LIAN.Y | $5.52M | $0.05 | -12.45% |
| Alpha Compute CorpNasdaqCM: ALP | $5.27M | $3.40 | -14.36% |
| Marvel Biosciences Corp.TSXV: MRVL | $5.22M | CA$0.10 | -13.04% |
| AIM ImmunoTech Inc.NYSEAM: AIM | $5.12M | $0.17 | -6.61% |
Figures last refreshed Oct 18, 2026.